AB-680 is highly potent, reversible and selective CD73 inhibitor. AB680 to be a reversible, slow-onset competitive inhibitor of human CD73 with a Ki of 5 pM. Clinical candidates of this potency are uncommon and deserve special consideration during lead optimization. AB680 is the first small molecule CD73 inhibitor in the clinic.
For research use only. We do not sell to patients.